What is a specialty pharmaceutical company | Explore Forecast and Insights 2025

What is a specialty pharmaceutical company?

This growth is largely due to rising incidences of chronic diseases such as cancer, rheumatoid arthritis, and multiple sclerosis, which demand highly specialized treatment regimens. 

Technological breakthroughs in biologics and gene therapy are reshaping the landscape, while growing FDA approvals for orphan and specialty drugs are fast-tracking commercial deployment. In addition, the increasing emphasis on personalized medicine and expanding healthcare access in emerging economies are fueling demand. Major trends include specialty drug delivery innovations, strategic collaborations between biotech and pharma players, and an increase in specialty drug expenditure among payers and providers.

List of the specialty pharmaceutical company

1. Novartis AG

Novartis develops innovative specialty drugs and biosimilars, targeting oncology, ophthalmology, neuroscience, and rare diseases. Its robust pipeline and global reach make it a key player in advanced therapeutics.

2. Sentrex Health Solutions

Sentrex is a specialty pharmacy services provider offering sterile compounding, distribution, and support for complex therapies like oncology, infertility, and MS. Its care coordination and technology platform enhance patient management.

3. GlaxoSmithKline plc (GSK)

GSK focuses on specialty medicines and vaccines for respiratory, HIV, oncology, and immuno-inflammation. As a leading biopharma, it delivers targeted therapies and strong R&D capabilities.

4. Cipla Ltd.

Cipla offers a broad range of specialty pharmaceuticals, including inhalers, injectables, oncology, and antiretroviral medicines. It is known for affordable access to advanced therapies in global markets.

5. Lupin Ltd.

Lupin is a global specialty pharma leader, focusing on cardiovascular, respiratory, metabolic, and central nervous system therapies. It is recognized for its complex generics, biosimilars, and a strong presence across emerging markets.

6. Xellia Pharmaceuticals

Xellia specializes in injectable anti-infectives, including vancomycin and polymyxin B. Its focus on hospital-based specialty treatments supports critical care and infectious disease management.

7. Ajanta Pharma Ltd.

Ajanta Pharma is a specialty generics company with a strong presence in ophthalmology, cardiology, dermatology, and anti-infectives. It markets branded and generic formulations across over 30 countries.

8. Taro Pharmaceutical Industries Ltd.

Taro develops, manufactures, and markets specialty dermatology, respiratory, and over-the-counter pharmaceuticals globally. Its R&D-driven approach supports both branded and generic portfolios.

9. Akorn Pharmaceuticals, Inc.

Akorn is a specialty pharma company focusing on ophthalmics, injectables, and respiratory products. It provides branded, generic, and OTC medications to diverse healthcare sectors.

10. Ethypharm

Ethypharm is a specialty pharma company targeting CNS disorders and hospital injectables. It emphasizes patient-centric products and niche hospital-based therapy solutions.

Frequently Asked Questions About the Market Study (FAQs):